Sindrome.del.Ovario.Poliquistico

Epidemiología y conceptos generales 21
2
Stein IF, Leventhal ML. Amenorrhea
associated with bilateral polycystic ovaries.
Am J Obstet Gynecol. 1935;29:
181-91.
3
Rebar R, Judd HL, Yen SCC, Vandenberg
G, Naftolin F. Characterization of
the inappropiate gonadotropin secretion
in polycystic ovary syndrome. J Clin
Invest. 1976;57:1320-9.
4
Burghen GA, Givens JR, Kitabchi AE.
Correlation of hyperandrogenism with
hyperinsulinism in polycystic ovarian
disease. J Clin Endocrinol Metab. 1980;
50:113-6.
5
Swanson M, Sauerbrie EE, Cooperberg
PL. Medical implications of ultrasonically
detected polycystic ovaries. J Clin
Ultrasound. 1981;9:219-22.
6
Adams J, Franks S, Polson DW, Mason
HD, Abdulwahid N, Jacobs HS. Multifollicular
ovaries: clinical and endocrine
features and response to pulsatile gonadotrophin
releasing hormone. Lancet.
1985;ii:1375-8.
7
Zawadzki JK, Dunaif A. Diagnostic
criteria for polycystic ovary syndrome:
towards a rational approach. In: Dunaif
A, Givens JR, Haseltine F, Merriam GR,
editors. Polycystic ovary syndrome. Boston:
Blackwell; 1992. p. 377-84.
8
Balen AH, Dunger D. Pubertal maturation
of the internal genitalia. Ultrasound
Obstet Gynecol. 1995;6:164-5.
9
Balen AH. The pathogenesis of polycystic
ovary syndrome: the enigma
unravels. Lancet. 1999;354:966-7.
10
The Rotterdam ESHRE/ASRM-saponsered
PCOS consensus workshop group.
Revised 2003 consensus on diagnostic
criteria and long-term health risks
related to polycystic ovary syndrome
(PCOS). Hum Reprod. 2004;19:41-7.
11
Elting MW, Korsen TJ, Rekers-Mombarg
LT, Schoemaker J. Women with
polycystic ovary syndrome gain regular
mentrual cycles when ageing. Hum
Reprod. 2000;15:24-8.
12
Bridges NA, Cooke A, Healy MJR,
Hindmarsh PC, Brook CGD. Standards
for ovarian volume in childhood and
puberty. Fertil Steril. 1993;60:456-60.
13
Knochenhauer ES, Key TJ, Kahsar-
Miller M, Waggoner W, Boots LR, Azziz
R. Prevalence of the Polycystic Ovary
Syndrome in unselected black and white
women of the southeastern United
States: a prospective study. J Clin Endocrinol
Metab. 1998;83:3078-82.
14
Diamanti-Kandarakis E, Kouli CR, Bergiele
AT, Filandra FA, Tsianateli TC, Spina
GG, et al. A survey of the polycystic
ovary syndrome in the greek island of
Lesbos: Hormonal and metabolic profile.
J Clin Endocrinol Metab. 1999;84:
4006-11.
15
Asunción M, Calvo RM, San Millán JL,
Sancho J, Ávila S, Escobar-Morreale HF.
A prospective study of the prevalence of
the polycystic ovary syndrome in unselected
caucasian women from Spain. J
Clin Endocrinol Metab. 2000;85:2434-48.
16
Carmina E, Koyama T, Chang L, Stanczyk
FZ, Lobo RA. Does ethnicity influence
the prevalence of adrenal hyperandrogenism
and insulin resistance
in polycystic ovary syndrome? Am J
Obstet Gynecol. 1992;167:1807-12.
17
Weiss DJ, Richards C, Dunaif A.
Increased prevalence of polycystic ovary
disease in Hispanic women (Abstract).
Clin Res. 1987;35:796 A.
18
Clayton RN, Hogkinson J, Worswick L,
Rodin DA, Dyer S, Meade TW. How common
are polycystic ovaries in normal
women and wath is their significance
for the fertility of the population? Clin
Endocrinol. 1992;37:127-34.
19
Rodin DA, Bano G, Bland JM, Taylor
K, Nussey SS. Polycystic ovaries and
associated metabolic abnormalities in
Indian subcontinent Asian women. Clin
Endocrinol. 1998;49:91-9.
20
Hague W, Adams J, Reeders ST, Peto
TEA, Jacobs HS. Familial polycystic ovaries:
a genetic disease. Clin Endocrinol.
1988;29:593-605.
21
Agrawal R, Sharma S, Bekir J, Conway
G, Bailey J, Balen AH, et al. Prevalence